Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Harry J. who wrote (98)	6/13/2002 11:21:20 AM
From: Skywatcher	Read Replies (1) \| Respond to of 174

that's great news..... cc

To: Harry J. who wrote (98)	6/28/2002 3:57:20 PM
From: Skywatcher	Respond to of 174

Cardiac Science Announces $1.3 Million Sale of Defibrillators and Patient Monitors Sold to Hospitals in Saudi Arabia, Turkey, Pakistan and Iran International Sales Contributing to Strong Revenue Growth in Quarter IRVINE, Calif., June 28 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (Nasdaq: DFIB) today announced that it has been selected to outfit hospitals in Saudi Arabia, Turkey, Pakistan and Iran with 138 Artema(R)-brand patient monitors and 50 emergency defibrillators. The orders shipped during this quarter to local Cardiac Science distribution partners in the four countries totaled approximately $1.3 million. The equipment will be used to outfit an expansion of an existing Artema(R)-equipped Intensive Care Unit (ICU) at Faneteer Hospital in Eastern Saudi Arabia and installed in various Khaneh Sazie hospitals in Iran, as well as an ICU in the Children's Hospital in Lahore, Pakistan and numerous ICU departments at hospitals in Turkey. Cardiac Science President and CEO Raymond W. Cohen, said, "These international orders are indicative of the strong efforts of our global distributors to leverage existing customer relationships and the large installed base of Artema products. We are currently experiencing a high level of activity and significant demand from international emergency response, hospital and medical organizations for our Powerheart(R) AED product as well as our hospital defibrillators and monitors. As a result, we expect sales for the second quarter of 2002 in our international market segment to exceed $3 million, which is nearly double what we estimated." Emergency defibrillators and patient monitors sold exclusively into international markets have become an important part of the Cardiac Science product line since the Company purchased Stockholm-based Artema Medical AB last November. The purchase of Artema, in addition to contributing international revenue and a broader product offering, has resulted in significant distribution synergy and has facilitated the sale of Cardiac Science core Powerheart products into the Artema distribution network in Europe, the Middle East and Asia. Pretty serious cash for a little guy. Don't see that it will come back down too much....and this should make sure it's in the 2000 CC